The immunoadjuvant toll-like receptor 5 (TLR5), Entolimod, which has already been used in clinical practice, can exert anti-metastatic effects and keep immune memory in CT26 tumor cell induced CRC model through the NK-DC-CD8+ T-cell axis [37]. This evidence concerns the gene TLR5 and colorectal carcinoma.